title: [Prescription of psychotropic medicines to pregnant women in Nord-Pas-de-Calais, France].
abstract: OBJECTIVE
  Prescription of psychotropic medicines carries risks to pregnancy. It is therefore appropriate to measure the prescription rate of these compounds in pregnant women.
  
  
  METHODS
  We studied the prescription rate for psychotropic agents to pregnant women from the Cnamts medicines reimbursement data and we compared this to prescriptions in non-pregnant women in the same age group.
  
  
  RESULTS
  There is a fall in the use of psychotropic agents in women during pregnancy compared to a non-pregnant population of the same age. Pregnant women receive 2.17 times less psychotropic agents. Nevertheless, approximately one out of every twenty women is prescribed a proprietary product with known risk to the neonate and four out of a thousand are prescribed a proprietary product which carries a risk of malformation during the first trimester.
  
  
  CONCLUSIONS
  Medical practice takes account of embryo-fetal risk in prescribing psychotropic agents in general although more communication is needed about the risk of some compounds during pregnancy.
authors.affiliation: Fédération régionale de Recherche en Santé mentale Nord-Pas-de-Calais, Lille, France. thierry.danel@santementale5692.com
authors.forename: Thierry
authors.initials: T
authors.lastname: Danel
authors.forename: Laurent
authors.initials: L
authors.lastname: Plancke
authors.forename: Alina
authors.initials: A
authors.lastname: Amariei
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Benoit
authors.forename: Sophie
authors.initials: S
authors.lastname: Gautier
authors.forename: Corinne
authors.initials: C
authors.lastname: Capele
authors.forename: Guillaume
authors.initials: G
authors.lastname: Vaiva
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D005602:France; D006801:Humans; D007231:Infant, Newborn; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011619:Psychotropic Drugs / Q000008:administration & dosage* / Q000009:adverse effects; D055815:Young Adult
chemical_list: D011619:Psychotropic Drugs